Clinical and microbiological profiles of human immunodeficiency virus (HIV)-seropositive Brazilians undergoing highly active antiretroviral therapy and HIV-seronegative Brazilians with chronic periodontitis

被引:58
|
作者
Goncalves, Lucio de Souza
Soares Ferreira, Sonia Maria
Souza, Celso Oliveira
Souto, Renata
Colombo, Ana Paula [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Sch Dent, BR-21941 Rio De Janeiro, Brazil
关键词
highly active antiretroviral therapy; HIV infection; periodontitis;
D O I
10.1902/jop.2007.060040
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: This study compares the periodontal clinical profile and the composition of the subgingival microbiota of human immunodeficiency vir-us (HIV)-seropositive and HIV-seronegative subjects with chronic periodontitis. Methods: A total of 172 subjects were distributed into two HIV-seropositive groups (37 chronic periodontitis [H+CP+] and 35 periodontally healthy [H+CP-] individuals) and two HIV-seronegative groups (49 chronic periodontitis [H-CP+] and 51 periodontally healthy [H-CP-] subjects). Subgingival samples were collected from six sites with the deepest probing depth in the periodontitis groups and six random sites in the groups with periodontal health. All HIV-infected patients had undergone highly active antiretroviral therapy (HAART) for at least 2 years. The presence and levels of 33 bacterial species were detected by DNA probes and the checkerboard method. Kruskal-Wallis and Mann-Whitney tests were used to seek for significant differences among and between groups. Results: H-CP+ patients showed significantly more periodontal destruction and inflammation than H+CP+ patients, whereas H+CP- subjects presented a greater percentage of sites with bleeding than H-CP- subjects (P < 0.01). Patients who were HIV seronegative showed higher prevalence and levels of most bacterial species than HIV seropositive patients. Periodontal pathogens including Tannerella forsythensis, Porphyromonas gingivalis, Prevotella nigrescens, Eubacterium nodatum, Fusobacterium nucleatum, and Selenomonas noxia were more frequently detected in H-CP+ subjects compared to H+CP+ and controls. In contrast, Enterococcus faecalis and Acinetobacter baumannii were more commonly found in HIV-infected than in non-HIV-infected subjects (P < 0.05). Conclusion: Putative periodontal pathogens are more prevalent in the subgingival microbiota of HIV-seronegative patients with chronic periodontitis, whereas species not usually associated with periodontitis are detected in higher frequency in HIV-seropositive subjects under HAART.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 50 条
  • [1] Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy
    Weinberg, A
    Pott, GB
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (05) : 821 - 825
  • [2] Cutaneous microenvironment of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative individuals, with special reference to Staphylococcus aureus colonization
    Shapiro, M
    Smith, KJ
    James, WD
    Giblin, WJ
    Margolis, DJ
    Foglia, AN
    McGinley, K
    Leyden, JJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3174 - 3178
  • [3] DEVELOPMENT OF ANAL SQUAMOUS INTRAEPITHELIAL LESIONS AMONG HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SEROPOSITIVE AND HIV-SERONEGATIVE HOMOSEXUAL MEN
    CRITCHLOW, C
    DALING, J
    HOLMES, K
    KUYPERS, J
    SAYER, J
    HURT, C
    SURAWICZ, C
    HART, P
    DUNPHY, C
    GOLDBAUM, G
    KIVIAT, N
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (08) : 588 - 589
  • [4] Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women
    Schuman, P
    Ohmit, SE
    Klein, RS
    Duerr, A
    Cu-Uvin, S
    Jamieson, DJ
    Anderson, J
    Shah, KV
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01): : 128 - 136
  • [5] IL-1 gene polymorphism and periodontal status of HIV Brazilians on highly active antiretroviral therapy
    Goncalves, Lucio de S.
    Ferreira, Sonia Maria S.
    Souza, Celso O.
    Colombo, Ana Paula V.
    [J]. AIDS, 2006, 20 (13) : 1779 - 1781
  • [6] Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (HAART)
    Kumar, N. Sum
    Shashibhushan, J.
    Malappa
    Venugopal, K.
    Vishwanatha, Hugo
    Menon, Mahesh
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (07) : 5 - 8
  • [7] Clinical treatment outcomes of periodontal therapy in HIV-seropositive patients undergoing highly active antiretroviral therapy
    Jordan, A. R.
    Gaengler, P.
    Joehren, H. -P.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2006, 11 (06) : 232 - 235
  • [8] Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan
    Juffermans, NP
    Verbon, A
    van Deventer, SJH
    van Deutekom, H
    Belisle, JT
    Ellis, ME
    Speelman, P
    van der Poll, T
    [J]. INFECTION AND IMMUNITY, 1999, 67 (08) : 4295 - 4297
  • [9] Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women
    Cu-Uvin, S
    Hogan, JW
    Warren, D
    Klein, RS
    Peipert, J
    Schuman, P
    Holmberg, S
    Anderson, J
    Schoenbaum, E
    Vlahov, D
    Mayer, KH
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) : 1145 - 1150
  • [10] Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection
    Heath, KV
    Montaner, JSG
    Bondy, G
    Singer, J
    O'Shaughnessy, MV
    Hogg, RS
    [J]. CURRENT DRUG TARGETS, 2003, 4 (01) : 13 - 22